GlucoTrack
GCTK
8 hedge funds and large institutions have $163K invested in GlucoTrack in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
73% less capital invested
Capital invested by funds: $594K → $163K (-$431K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$3.98K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.65K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$349K |
| 2 |
CHP
Cable Hill Partners
Portland,
Oregon
|
-$8.69K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$7.88K |
| 4 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$6.63K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.33K |
GCTK Hedge Fund Activity: Q4 2023 in Review
8 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2023, worth a combined $163K — down 73% from $594K a quarter earlier.
Fund positioning in GCTK was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $3.98K. The largest seller was Sabby Management, cutting an estimated $349K.
- 8 institutional investors held GlucoTrack (GCTK) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $163K of GlucoTrack stock for Q4 2023, down 73% quarter-over-quarter.
- 2 funds opened new GlucoTrack positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest GlucoTrack buyer in Q4 2023 was Virtu Financial, an estimated $3.98K added.
- The largest GlucoTrack seller in Q4 2023 was Sabby Management, an estimated $349K sold.
Based on aggregated 13F filings for Q4 2023.